Clinical Trial Update: The IDEAL-PCI Extended Registry [Phase 4]

View source ↗

Summary

The IDEAL-PCI Extended Registry trial (Phase 4) has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Arteriosclerosis
• Platelet Dysfunction Due to Drugs

Snippet

Sponsor: Kaiser Franz Josef Hospital | Conditions: Coronary Arterioscleroses, Platelet Dysfunction Due to Drugs | Phase 4 | Status: WITHDRAWN